GetTopicDetailResponse(id=ecfa1189e8f8, topicName=TROP2, introduction=, content=TROP2 科倫博泰 蘆康沙妥珠單抗, image=null, comments=0, allHits=580, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Sep 12 03:58:14 CST 2024, time=2024-09-12, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=104728, tagList=[TagDto(tagId=104728, tagName=TROP2)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2277399, encodeId=c5e922e73996b, content=<a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宮頸癌#</a> <a href='/topic/show?id=ecfa1189e8f8' target=_blank style='color:#2F92EE;'>#TROP2#</a>, objectTitle=原發(fā)、轉(zhuǎn)移和復(fù)發(fā)性宮頸癌TF/TROP2/NECTIN4蛋白表達(dá)情況，鱗癌和腺鱗癌重點(diǎn)關(guān)注, objectType=article, longId=891849, objectId=c39f891849f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-P765AZE.jpg, objectUrl=/article/show_article.do?id=c39f891849f1, replyNumber=0, likeNumber=11, createdTime=2025-08-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c39f891849f1, moduleTitle=原發(fā)、轉(zhuǎn)移和復(fù)發(fā)性宮頸癌TF/TROP2/NECTIN4蛋白表達(dá)情況，鱗癌和腺鱗癌重點(diǎn)關(guān)注, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c39f891849f1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225307, encodeId=1f19222530e40, content=<a href='/topic/show?id=ecfa1189e8f8' target=_blank style='color:#2F92EE;'>#TROP2#</a> <a href='/topic/show?id=dbe010e367ba' target=_blank style='color:#2F92EE;'>#科倫博泰#</a> <a href='/topic/show?id=028c1189e9f3' target=_blank style='color:#2F92EE;'>#蘆康沙妥珠單抗#</a>, objectTitle=ESMO 2024： 科倫博泰Trop2 ADC蘆康沙妥珠單抗三項(xiàng)臨床研究結(jié)果亮眼, objectType=article, longId=842801, objectId=6c4284280162, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240911/57a9e7cd2ad6475ba1a0981e502e7626-T8Qc9z3wtUHA.jpg, objectUrl=/article/show_article.do?id=6c4284280162, replyNumber=0, likeNumber=81, createdTime=2024-09-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=6c4284280162, moduleTitle=ESMO 2024： 科倫博泰Trop2 ADC蘆康沙妥珠單抗三項(xiàng)臨床研究結(jié)果亮眼, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6c4284280162)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-09-12發(fā)表于威斯康星
